The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases
- PMID: 33006052
- DOI: 10.1007/s12012-020-09609-y
The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases
Abstract
The MG53 (also known as TRIM72) is a conserved, muscle-specific tripartite motif family protein that is abundantly expressed in cardiac or skeletal muscle and present in circulation. Recently, the MG53 had been hypothesized to serve a dual role in the heart: involving in repairing cell membranes that protect myocardial function while acting as an E3 ligase to trigger insulin resistance and cardiovascular complications. This review discusses the roles of MG53 in cardiac physiological function with emphasis on MG53 protective function in the heart and its negative impact on the myocardium due to the continuous elevation of MG53. Besides, this work reviewed the significance of MG53 as a potential therapeutic in human cardiovascular diseases. Despite the expression of MG53 being rare in the human, thus exogenous MG53 can potentially be a new treatment for human cardiovascular diseases. Notably, the specific mechanism of MG53 in cardiovascular diseases remains elusive.
Keywords: Cardiovascular diseases; Insulin resistance; Ischemic cardiomyopathy; MG53.
Similar articles
-
Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.Circulation. 2019 Feb 12;139(7):901-914. doi: 10.1161/CIRCULATIONAHA.118.037216. Circulation. 2019. PMID: 30586741
-
MG53 is a double-edged sword for human diseases.Sheng Li Xue Bao. 2016 Aug 25;68(4):505-16. Sheng Li Xue Bao. 2016. PMID: 27546510 Review.
-
Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.Circulation. 2015 Mar 3;131(9):795-804. doi: 10.1161/CIRCULATIONAHA.114.012285. Epub 2015 Jan 30. Circulation. 2015. PMID: 25637627
-
Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.Cardiovasc Res. 2016 May 15;110(2):178-87. doi: 10.1093/cvr/cvw017. Epub 2016 Jan 19. Cardiovasc Res. 2016. PMID: 26790476 Free PMC article.
-
MG53: Biological Function and Potential as a Therapeutic Target.Mol Pharmacol. 2017 Sep;92(3):211-218. doi: 10.1124/mol.117.108241. Epub 2017 Apr 21. Mol Pharmacol. 2017. PMID: 28432201 Review.
Cited by
-
Estradiol regulates oxidative stress and angiogenesis of myocardial microvascular endothelial cells via the CDK1/CDK2 pathway.Heliyon. 2023 Mar 4;9(3):e14305. doi: 10.1016/j.heliyon.2023.e14305. eCollection 2023 Mar. Heliyon. 2023. PMID: 36942258 Free PMC article.
-
Protective role of MG53 against ischemia/reperfusion injury on multiple organs: A narrative review.Front Physiol. 2022 Nov 21;13:1018971. doi: 10.3389/fphys.2022.1018971. eCollection 2022. Front Physiol. 2022. PMID: 36479346 Free PMC article. Review.
-
A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy.Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231210170. doi: 10.1177/17539447231210170. Ther Adv Cardiovasc Dis. 2023. PMID: 38069578 Free PMC article. Review.
-
YTHDF2 mediates the protective effects of MG53 on myocardial infarction injury via recognizing the m6A modification of MG53.J Cardiothorac Surg. 2025 Feb 8;20(1):121. doi: 10.1186/s13019-024-03210-y. J Cardiothorac Surg. 2025. PMID: 39923081 Free PMC article.
-
Integrated transcriptomic and proteomic analysis reveals potential targets for heart regeneration.Biomol Biomed. 2023 Feb 1;23(1):101-113. doi: 10.17305/bjbms.2022.7770. Biomol Biomed. 2023. PMID: 35997993 Free PMC article.
References
-
- Parky, E. Y., Kwony, O. B., Jeong, B. C., Yi, J. S., Lee, C. S., Ko, Y. G., et al. (2010). Crystal structure of PRY-SPRY domain of human TRIM72. Proteins, 78(3), 790–795.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources